The Clinical and Translational Science Institute (CTSI) at UC San Francisco (UCSF), a unit within the Office of Research, will support, coordinate and respond to COVID-19 research needs. Some of CTSI’s efforts to support impactful COVID-19 research include:
Elissa Epel, PhD, a health psychologist, is interested in stress and how it gets under the skin to affect cellular and cardiometabolic health. She studies how the environment, social context, and mind states affect stress and metabolic health.
Payam Nahid, MD, MPH, has been appointed as associate director, Clinical Trials Operations (CTO), in the Office of Research after a competitive internal UCSF search. In his new role, Dr. Nahid will collaborate closely with the associate vice chancellor of Clinical Research and the rest of the Office of Research leadership.
The Trial Innovation Network (TIN) is a collaborative initiative within the CTSA Program and is composed of three key partners – the CTSA Program Hubs, the Trial Innovation Centers (TICs), and the Recruitment Innovation Center (RIC).